Phase II trial of gemcitabine, epirubicin, and G-CSF in patients with metastatic pancreatic cancer

被引：0
|
作者：
Raderer, M
Kornek, GV
Valencak, J
Lenauer, A
Flebiger, W
Greul, R
Lang, F
Schneeweiss, B
Depisch, D
Scheithauer, W
机构：
[1] Univ Vienna, Dept Internal Med 1, A-1010 Vienna, Austria
[2] AoKH Kirchdorf Krems, Dept Internal Med, Krems, Austria
[3] Wr Neustadt, Dept Surg, Vienna, Austria
[4] Neunkirchen Gen Hosp, Dept Surg, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
648
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [21] Gemcitabine in advanced pancreatic cancer -: A phase II trial
    Crinò, L
    Mosconi, AM
    Calandri, C
    Corgna, E
    Porrozzi, S
    Chiara, S
    Nobili, MT
    Tonato, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 296 - 298
  • [22] A phase II study of triapine in combination with gemcitabine (G) in patients (pts) with unresectable or metastatic pancreatic cancer (PC).
    Greeno, E.
    Kindler, H. L.
    Peeters, M.
    Trowbridge, R. C.
    Chong, G.
    Valle, J. W.
    Johnson, B.
    Allain, E. L.
    Burris, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 208S - 208S
  • [23] Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial
    Cereda, Stefano
    Reni, Michele
    Rognone, Alessia
    Fugazza, Clara
    Ghidini, Michele
    Ceraulo, Domenica
    Brioschi, Matteo
    Nicoletti, Roberto
    Villa, Eugenio
    CHEMOTHERAPY, 2011, 57 (02) : 156 - 161
  • [24] A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
    Oettle, H
    Richards, D
    Ramanathan, RK
    van Laethem, JL
    Peeters, M
    Fuchs, M
    Zimmermann, A
    John, W
    Von Hoff, D
    Arning, M
    Kindler, HL
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1639 - 1645
  • [25] Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer A Phase II Study
    Safran, Howard
    Miner, Thomas
    Bahary, Nathan
    Whiting, Sam
    Lopez, Charles D.
    Sun, Weijing
    Charpentier, Kevin
    Shipley, Joshua
    Anderson, Elliot
    McNulty, Brendan
    Schumacher, Andrew
    Clark, Alessandra
    Vakharia, Jamsheed
    Kennedy, Teresa
    Sio, Terence
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 50 - 52
  • [26] Lapatinib and gemcitabine for metastatic pancreatic cancer: A phase II study
    Safran, H.
    Miner, T.
    Bahary, N.
    Whiting, S.
    Lopez, C.
    Sun, W.
    Charpentier, K.
    Charpentier, K.
    Shipley, J.
    Anderson, E.
    McNulty, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer -: A phase II study
    Hausmaninger, H
    Morack, G
    Heinrich, B
    Wallwiener, D
    Höffken, K
    Buksmaui, S
    Krejcy, K
    Miller, MA
    Possinger, K
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (04): : 429 - 435
  • [28] Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer
    Kaufman, D
    Raghavan, D
    Carducci, M
    Levine, EG
    Murphy, B
    Aisner, J
    Kuzel, T
    Nicol, S
    Oh, W
    Stadler, W
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1921 - 1927
  • [29] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
  • [30] Phase II trial of bevacizurnab plus gemcitabine in patients with advanced pancreatic cancer
    Kindler, HL
    Friberg, G
    Singh, DA
    Locker, G
    Nattam, S
    Kozloff, M
    Taber, DA
    Karrison, T
    Dachman, A
    Stadler, WM
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8033 - 8040
12345